UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

SYNERGETICS USA, INC.

(Exact name of registrant as specified in its charter)

Delaware		000-51602		20-5715943
(State or other jurisdiction of		(Commission		(I.R.S. Employer
incorporation)		File Number)		Identification No.)

3845 Corporate Centre Drive
O’Fallon, Missouri		63368
(Address of principal executive offices)		(Zip Code)

(636) 939-5100
(Registrant’s telephone number, including area code)

          Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

	o		Written communications pursuant to Rule 425 under the Securities Act.
	o		Soliciting material pursuant to Rule 14a-12 under the Exchange Act.
	o		Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
	o		Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

 

 

Item 7.01. Regulation FD Disclosure.

     On December 6, 2007, the presentation attached hereto as Exhibit 99.1 and incorporated herein by reference was delivered to stockholders of Synergetics USA, Inc. (the “Company”) following the Company’s 2007 Annual Meeting of Stockholders.

Item 9.01. Financial Statements and Exhibits.

(d)

Exhibits.

Exhibit No.		Description of Exhibit
99.1		Presentation delivered at the Synergetics USA, Inc. Annual Meeting of Stockholders on December 6, 2007.

SIGNATURES

     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: December 6, 2007

		SYNERGETICS USA, INC. (Registrant)
		By:		/s/ Pamela G. Boone
		Name:		Pamela G. Boone
		Title:		President and Chief Executive Officer